Papers: 10.3390/jpm11050330

https://doi.org/10.3390/jpm11050330

The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology

Cited by: 1
Author(s): Sigve Nakken, Wolfgang Lilleby, Marta D. Switlyk, Karen E. Knudsen, Oscar Lilleby, Sen Zhao, Fatemeh Kaveh, Per Olaf Ekstrøm, Alfonso Urbanucci, Eivind Hovig
Published: over 4 years ago

Software Mentions 2